Secrecy about pharmaceutical products
- Lack of public access to information on medicines
Incidence
In the UK, it is a criminal offence for officials involved in the licensing or withdrawal of a drug to disclose any information about their decision. Although the manufacturers of drugs are required to produce data sheets that identify likely side-effects, there is no public right of access to these safety studies.
Claim
Evidence based medicine has been corrupted by corporate interests, failed regulation, and commercialisation of academia
Broader
Narrower
Aggravates
Aggravated by
Related
Strategy
Value
Web link
SDG
Metadata
Database
World problems
Type
(F) Fuzzy exceptional problems
Biological classification
N/A
Subject
Defence » Secrecy
Government » Public
Health care » Pharmacy
Industry » Products
Information » Information
Societal problems » Scarcity
Content quality
Yet to rate
Language
English
1A4N
J5098
DOCID
12050980
D7NID
140408
Last update
Nov 3, 2022